↓ Cooling
Business
Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles
3sources
3articles
1velocity
-63%since first seen
1h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (3)
- Vertex to acquire Crinetics in $10B foray into endocrine disease drugs BioPharma Dive · 5h ago
- Biggest stock movers Tuesday: CRNX, RIVN, DOCN, and more Seeking Alpha · 5h ago
- Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles Investor's Business Daily · 5h ago
Related trends
▲ Peaking
Business
Meta enters AI image model race in bid to court advertisers and subscribers
Meta has launched Muse Image, an in-house AI image generation model targeting consumers, advertisers, and subscribers.
▲ Peaking
Business
Trump promised to cut electric bills in half. His energy policy is doing the opposite, new analysis finds
New analysis suggests Donald Trump's energy policies are increasing electricity costs despite his promise to cut bills in half.
▲ Peaking
Business
Micron Got Its Final Warning (Rating Downgrade) (NASDAQ:MU)
Micron (NASDAQ:MU) faces stock volatility and a rating downgrade amid investor uncertainty regarding the memory market peak.
▲ Peaking
Business
Oil prices rise as attacks revive safety concerns in the Strait of Hormuz
▲ Peaking
Business
SK Hynix US Listing Said to Be Multiple Times Oversubscribed
▲ Peaking
Business